- Frencken expects to see a gradual recovery in its major segments, including the semiconductor and life science segments. However, its automobile segment could see a slower ramp-up as major customers have yet to make their final decisions on whether to select new energy or traditional vehicles.
- - Read this at SGinvestors.io -
Diversified business with ability to share core competencies; focusing on customers who are leaders in their field.
- Frencken (SGX:E28) highlighted that it provides diversified integrated manufacturing solutions for multinational companies in the semiconductor, analytical life sciences, automobile, healthcare and industrial automation sectors.
- - Read this at SGinvestors.io -
- In the semiconductor segment, Frencken has moved from a supplier of components to an entire fab processing system. In addition, it focuses on customers who are leaders in their field and it aims to be relevant and grow together with its customers.
Expect gradual recovery for major segments including semiconductor and analytical life sciences.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
John Cheong UOB Kay Hian Research | https://research.uobkayhian.com/ 2024-10-15
Read also UOB's most recent report:
2024-11-20 Frencken - 3Q24 Results Below Expectations; Expect Gradual Recovery.
Price targets by 4 other brokers at Frencken Target Prices.
Listing of research reports at Frencken Analyst Reports.
Relevant links:
Frencken Share Price History,
Frencken Announcements,
Frencken Dividends & Corporate Actions,
Frencken News Articles
